Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing meglumine diatrizoate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing meglumine diatrizoate and sodium diatrizoate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diatrizoate meglumine 66%/sodium diatrizoate 10% solution 120mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 30% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine + diatrizoate sodium 520mg/80mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 527mg/iodipamide meglumine 268mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 300mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 180mg + iodine 85mg/mL (18%) injection solution 300mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 2000mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1000mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1250mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 66%/sodium diatrizoate 10% solution 240mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing meglumine amidotrizoate in parenteral dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diatrizoate meglumine 66%/sodium diatrizoate 10% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meglumine amidotrizoate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|